Latest filing published 21 Jun 2019 for Mimedx Group, INC., €31k.
No signal scores available.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Joseph G. Bleser across 3 companies, led by Mimedx Group, Inc., Transcend Services Inc and Matria Healthcare Inc. Between 8 August 1998 and 20 June 2019, the trades on record add up to 19 filings.
The open-market side counts 4 purchases for €62k alongside 1 sale for €405k. On balance, insiders were net sellers of €343k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 7 share grants and 3 option exercises.
Half of the purchases are above €8,767 and half below. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -9.3%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 21 June 2019, reports an option exercise of €31k in Mimedx Group, Inc. The clock since the last published purchase (13 May 2013) now reads 4,911 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations